Not yet recruitingObservationalLast updated Aug 12, 2026

A Study to Monitor Safety and Effectiveness of Approved J&J MedTech Devices in the Treatment of Participants With Ischemic Stroke

A Post-market Observational Study to Monitor Safety and Effectiveness in the Treatment of Patients With Ischemic Stroke Using Commercially Approved J&J MedTech Devices Optimized for Neurovascular Thrombectomy

Overview

ClinicalTrials.gov ID: NCT07760649
Lead Sponsor: Neuravi LimitedINDUSTRY
Brief Summary: The purpose of this study is to collect medical information to monitor the ongoing safety of the J&J MedTech devices and to understand how well they work when routinely used to treat participants with acute ischemic stroke (a condition caused by a blocked blood vessel in the brain).
Study Type

Status

Overall Status: Not yet recruiting
Start Date: Aug 10, 2026Estimated
Primary Completion Date: Oct 16, 2030Estimated
Completion Date: Dec 31, 2030Estimated

Study Record Dates

First Submitted: Aug 7, 2026
First Submitted that Met QC Criteria: Aug 7, 2026
First Posted: Aug 12, 2026Actual
Last Update Submitted that Met QC Criteria: Aug 7, 2026
Last Update Posted: Aug 12, 2026Actual
Last Verified: Aug 2026

NCT05074186Completed

Assessing the Safety and Effectiveness of a Neurological Thrombectomy Medical Device for Acute Ischemic Stroke

NCT02239640Completed

Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry

NCT00334061Completed

Study to Assess the Safety and Effectiveness of the Penumbra System

NCT02586415Terminated

Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3

NCT03898960Completed

Post Marketing Study to Evaluate the NIMBUS Device

NCT02169492Completed

Evaluation of the ReVive SE Device for Intra-Arterial Thrombectomy in Acute Ischemic Stroke